World Evidence, Pricing and Access Congress

SKC consulting is pleased to announce its participation at the World Evidence, Pricing and Access (EPA) Congress, which will take place in Amsterdam from March 22^nd to 24^th, 2022. The congress is one of the largest in Europe, welcoming 250 speakers and over 1,000 attendees from the pharmaceutical and biotech industries.

Heike Kielhorn, managing director of SKC consulting, and Fenja Lang, head of business development, will participate at the congress and expect fresh input, especially on the topics "Market Access & Pricing", "Rare Diseases" and "Advanced Therapies", but also on the new areas for EPA Congress "Digital Health" or "HTA".

After last year's virtual conference, we can finally meet the decision makers of the industry on site this year. Are you also taking part? Please contact us in advance to arrange an appointment at the congress or use the congress portal swapcard to do so. We look forward to seeing you in Amsterdam!

For more information go to Terrapinn: World EPA Congress.